Genmab A/S (OTCMKTS:GNMSF) Share Price Passes Below 50 Day Moving Average – Time to Sell?

Genmab A/S (OTCMKTS:GNMSF)’s share price passed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $208.18 and traded as low as $205.00. Genmab A/S shares last traded at $205.00, with a volume of 60 shares traded.

Genmab A/S Stock Down 2.9%

The company’s 50-day simple moving average is $208.18 and its 200 day simple moving average is $205.82. The stock has a market capitalization of $13.54 billion, a price-to-earnings ratio of 11.63 and a beta of 0.91.

Genmab A/S (OTCMKTS:GNMSF) last issued its quarterly earnings data on Thursday, May 8th. The company reported $3.05 EPS for the quarter, beating analysts’ consensus estimates of $1.88 by $1.17. Genmab A/S had a return on equity of 19.23% and a net margin of 35.11%. The business had revenue of $765.14 million for the quarter, compared to analyst estimates of $761.09 million.

About Genmab A/S

Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; and Amivantamab for advanced or metastatic gastric or esophageal cancer and NSCLC.